Randomized clinical trial to evaluate the efficacy of two techniques against chronic hip pain: cooled radiofrequency over sensitive nerves of the hip, compared to intraarticular injection of steroids and local anestethic under fluoroscopic guidance on the hip. - Randomized trial: radiofrequency versus intraarticular local anesthestic and steroids.

JORGE ORDUÑA VALLS0 个研究点目标入组 20 人开始时间: 2018年4月9日最近更新: 2018年6月18日

适应症

试验速览

暂无简介。

•1- Patient over 18 years old.
•2- Chronic hip pain (more than 3 months) that has not responded to conservative treatment, pharmacological therapy, physiotherapy or TENS).
•3- Mechanical pain in the affected limb with a VAS of at least 50 mm during ambulation.
•4- Patients for whom it is possible to carry out all the scheduled visits of the study, with the capacity to attend within the established deadlines for the control visits.
•5- Greater than 50% improvement in the VAS scale after the two anesthetic blocks performed with local anesthetics of different duration (levobupivacaine 0.25% and mepivacaine 2%)
•6- Moderate to severe osteoarthrosis determined with degrees Kellgren-Lawrence II, III, IV.
•7- Stable doses of analgesics at least 30 days before starting the study.
•8- Patients who have performed the Oxford Hip Score and WOMAC test 3 months or less before the study.
•9- Absence of allergy or adverse events known to any of the medications administered: local anesthetics of amide group and iodinated contrasts.
•10-Negative pregnancy test (women of childbearing age) and commitment to guarantee contraception during the study
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 20
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 20

•1- Signs of alarm or infection in the joint affects.
•2- Signs of active infection, immunosuppression or active HIV.
•3- Severe psychiatric illnesses.
•4-Patient carrier of hip prosthesis.
•5- Pain added to an unexplained weight loss of more than 5% 90 days or less before the start of the study.
•6- Pain of root origin established in the affected limb, or neurodegenerative diseases of the peripheral nervous system.
•7- Patients with basic tumor pathology or who have had cancer in the five years prior to inclusion.
•8- Alterations of the coagulation or taking of anticoagulants / antiaggregants (except aspirin 150 or 300 mg / day) at the beginning of the study, which can not be suspended for basic pathology during a prudent interval for the realization of the technique.
•9- Patient who has participated in a clinical study for the previous 30 days in which interventions are performed that may affect the results of the study.
•10- Patient with a diagnosis of disorder due to substance abuse or alcoholism.
•11- Patient who is in process for the award of a disability or degree of disability.
•12- Pregnant or lactating patient.
•13- Patient under treatment with opioids with doses greater than the equivalent to 90 milligrams of oral morphine / day.

发起方

JORGE ORDUÑA VALLS